Home > Result Summaries: Compounds > naratriptan > Result Summary for C95-036

Result Summary for C95-036

Result Summary

Protocol ID:	C95-036
Clinical Study ID:	C95-036
Official Title:	A study to investigate the pharmacokinetics of oral naratriptan (GR85548A) in subjects with impaired hepatic function.
Phase:	Phase 1
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Abstract: The pharmacokinetics of oran naratriptan in subjects with impaired hepatic function. Fuseau, E, Kempsford, R D, and Moss, J 8th Congress of the International Headache Society 6/10/1997 Amsterdam, Netherlands Fuseau E: The pharmacokinetics of oral naratriptan in subjects with impaired hepatic function CEPHALALGIA 1997;17(3):409 Abstract: The pharmacokinetics of oral naratriptan in subjects with impaired hepatic function. Fuseau, E MD, Kempsford, RD MD, and Moss, J MD 39th Annual Scientific Meeting of the American Association for the Study of Headache 6/22/1997 New York, New York Abstract: The pharmacokinetics of oral naratriptan in subjects with impaired renal or hepatic function. E. Fuseau, R. D. Kempsford J. Moss P. Snell A. Crisp J. M. Noblel G. A. Fordl 16th World Congress of Neurology 9/14/1997 Buenos Aires, Argentina